Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products ...
Stocktwits on MSN1d
Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid VolatilityTonix Pharmaceuticals saw its shares swing wildly between gains and losses on Wednesday morning as they started to trade ...
MarketBeat on MSN7d
Is Tonix Pharmaceuticals the Next Biotech Breakout?Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...
EST Tonix Pharmaceuticals (TNXP) trading halted, news pendingMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...
Tonix Pharmaceuticals Holding Corp.’s TNXP share price has dipped by 54.47%, which has investors questioning if this is right ...
Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Tonix ...
CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and ...
Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback